Ignite Creation Date:
2025-12-24 @ 12:15 PM
Ignite Modification Date:
2025-12-27 @ 10:34 PM
Study NCT ID:
NCT03526861
Status:
COMPLETED
Last Update Posted:
2025-03-11
First Post:
2018-05-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Sponsor:
LEO Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-16
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-04
First Submit QC Date:
None
Study First Post Date:
2018-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-30
Results First Submit QC Date:
None
Results First Post Date:
2021-10-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-03-29
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-03-11
Last Update Post Date Type:
ACTUAL